McKesson (MCK) Stock Price & AI Analysis

NYSE
USA

$611.99

-$0.47
(-0.38%)

Subscribe to get
AI Score

McKesson Company Profile

McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs. The RxTS segment offers prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The International segment refers to the distribution and services to wholesale, institutional, and retail customers in Europe and Canada. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.
McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs. The RxTS segment offers prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The International segment refers to the distribution and services to wholesale, institutional, and retail customers in Europe and Canada. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

McKesson | Latest news

Jim Cramer Says McKesson Corporation (MCK) Is A ‘Trump Stock’

We recently published an article titled Jim Cramer Discussed 10 Stocks That Can Do Well in...

Insider Monkey - 8 hours ago

Here’s Why McKesson Corporation (MCK) was Down 15.2% in Q3

Alluvium Asset Management, an asset management company, released its “Conventum – Alluvium Global...

Insider Monkey - 2 days ago

Investors in McKesson (NYSE:MCK) have seen massive returns of 356% over the past...

Long term investing can be life changing when you buy and hold the truly great businesses. And we've...

Simply Wall St - 7 days ago

McKesson Co. (NYSE:MCK) Receives $631.57 Average Price Target from Analysts

McKesson Co. (NYSE:MCK – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the sixteen brokerages that are presently covering the stock, Marketbeat reports. Two investment ...

ETF DAILY NEWS - 1 day ago

Jim Cramer lists 10 stocks likely to perform well in December

CNBC's Jim Cramer on Monday listed ten stocks he thinks will do well in December, saying winners...

CNBC - 3 days ago

McKesson Co. (NYSE:MCK) Holdings Raised by Fisher Asset Management LLC

Fisher Asset Management LLC lifted its stake in McKesson Co. (NYSE:MCK – Free Report) by 50.0% in the third quarter, according to its most recent filing with the Securities & Exchange Commission ...

ETF DAILY NEWS - 5 days ago

Zacks Research Comments on McKesson’s Q3 Earnings (NYSE:MCK)

McKesson Co. (NYSE:MCK – Free Report) – Stock analysts at Zacks Research upped their Q3 2025 earnings per share (EPS) estimates for McKesson in a research note issued to investors on Wednesday ...

ETF DAILY NEWS - 3 days ago

All-Class 1A football: State champ Indian River earns 10 first-team spots, 2...

FB – Vaughn Brooks, jr., McK. RB – Jayvion Pollard, sr., Chr; Gino Greer, sr., Tat. WR – Jeremiah...

Delaware Online The News Journal - 3 days ago

Check out November's biggest stock market winners (and losers!)

...) , up 37.23% Tapestry (TPR) , up 31.25% EPAM Systems (EPAM) , up 29.30% Warner Bros Discovery...

TheStreet - 4 days ago

AT&T outlines grand plan to return $40B to shareholders, boost earnings - Dallas...

AT&T Inc. CEO John Stankey unveiled Dec. 3 a three-year plan to generate billions for shareholders...

The Business Journals - 2 days ago